InoteveraGaidhi rinotevera
AI Chest X-Ray Dudziro
Maindasitiri
Nhungamiro yehunyanzvi
AI can help genetic laboratories search literature, prioritize candidate variants, or organize evidence for review, but a model score is not a clinical classification.
Teerera kugwaro iriAI-yakarondedzerwa · ~3 min
ACMG/AMP guidance classifies variants using multiple evidence types and five categories, including uncertain significance; ClinGen expert panels refine criteria for particular genes and disorders. Clinical interpretation depends on phenotype, inheritance, population data, functional evidence, and expert review, with results communicated through qualified professionals.
A genetic variant is a difference in DNA sequence. Its clinical meaning is not obvious from the sequence alone: interpretation may require knowledge of the gene, disease mechanism, inheritance, the person’s phenotype, family segregation, population frequency, functional studies, and clinical observations. ACMG and AMP guidance provides a framework for classifying sequence variants into five categories: pathogenic, likely pathogenic, uncertain significance, likely benign, and benign. The categories are based on combinations of evidence criteria rather than a single model score. AI and computational tools can support curation by searching literature, extracting candidate evidence, or prioritizing variants for human review. A model may miss a relevant paper, misread an assay, overstate a computational prediction, or fail to apply a disease-specific criterion. ClinGen Variant Curation Expert Panels publish specifications that adapt guidance for particular genes or disorders. A result from one gene or population should not automatically be generalized to another. Clinical laboratories and qualified genetics professionals remain responsible for evidence evaluation, classification, and communication. A variant of uncertain significance is not a confirmed cause of disease and should not be used as if it were a pathogenic finding. Keep provenance for each evidence claim, check classifications against current criteria and databases, and state limitations clearly. AI can accelerate evidence organization, but it cannot replace validated curation, expert judgment, or patient-specific counseling. Record the reference genome build and transcript used.
A curator uses a model to find papers about a variant, then verifies each claim and source in the publication.
A laboratory compares computational predictions with population frequency, segregation, functional, and clinical evidence.
A genetic counselor explains a variant of uncertain significance without presenting it as a confirmed diagnosis.
A team documents which criteria support a classification and which evidence remains missing or contradictory.
Models may improve literature retrieval and evidence extraction as genomic datasets grow, but bias, population coverage, and classification criteria will remain important. Newer algorithms need validation on relevant genes and patient populations, and expert panels may update gene-specific rules. Laboratories should monitor guidance, document software versions, and keep a human review pathway. Patient and family communication should explain uncertainty in accessible terms. Versioned databases and evolving criteria make periodic re-review important. Experts should track reclassifications and communicate meaningful changes to affected patients.
Tsamba yemahara
Nhatu dzakasimbiswa dzeAI nyaya mangwanani ega ega pakati pevhiki, dzakanyorwa neChirungu chakajeka. Yemahara zvachose, hapana ads.
Imwe email zuva rega rega revhiki. Bvisa kunyoresa kamwe chete. Hatimbotengese kana kugovera kero yako.
Zviedze iwe pachako
Mhinduro yepakarepo pamhinduro yega yega, uye chitupa chinogovaniswa chine ID inobatika kana wapedza kosi.
Tsigira dzidzo yemahara yeAI. AI Understanding ndeye 501(c)(3) isingabatsiri - hapana ads, hapana paywall, zvachose. Ita chipo
AI can help genetic laboratories search literature, prioritize candidate variants, or organize evidence for review, but a model score is not a clinical classification. ACMG/AMP guidance classifies variants using multiple evidence types and five categories, including uncertain significance; ClinGen expert panels refine criteria for particular genes and disorders. Clinical interpretation depends on phenotype, inheritance, population data, functional evidence, and expert review, with results communicated through qualified professionals.
ACMG/AMP guidance defines five sequence-variant classification categories.
Computational evidence is one part of an evidence framework.
Retrieval locates a source but does not validate how it applies.
A ranking score is a prioritization aid, not a clinical conclusion.
Ramba uchidzidza
Mamwe madhairekitori akasarudzirwa nyaya iyi
InoteveraGaidhi rinotevera
AI Chest X-Ray Dudziro
Maindasitiri